InvestorsHub Logo
Followers 52
Posts 4107
Boards Moderated 0
Alias Born 07/03/2005

Re: None

Wednesday, 03/28/2018 7:19:49 AM

Wednesday, March 28, 2018 7:19:49 AM

Post# of 14944
https://seekingalpha.com/instablog/48068065-j-capital-research/5136173-terminal-patient

J Capital thinks Sorrento Therapeutics is a zero. We think management is trying to pump up the share price and personally benefit from options at the expense of the company’s underlying value. We think that management’s focus on creating personal wealth has actually destroyed the potential that Sorrento once had.
You should assume that J Capital is short SRNE shares directly or indirectly and therefore may have a conflict of interest. We encourage investors to undertake their own investigation.

unbelievable!

Opti

Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News